awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33726030-5FDBE0D5-D12B-48B4-96BE-8E1EA51A7226
Q33726030-5FDBE0D5-D12B-48B4-96BE-8E1EA51A7226
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33726030-5FDBE0D5-D12B-48B4-96BE-8E1EA51A7226
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents.
P2860
Q33726030-5FDBE0D5-D12B-48B4-96BE-8E1EA51A7226
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33726030-5FDBE0D5-D12B-48B4-96BE-8E1EA51A7226
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e74e6b66a88d4eec17cf9fe51b2e9cabe2f07cad
P2860
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis